dr. H.A.M. Mutsaers

No picture available
h.a.m.mutsaers rug.nl


Postal address:
A Deusinglaan1
9713 AV
Phone: +31 50 363 3284Fax: +31 50 363 2500
  1. 2020
  2. 2019
  3. 2018
  4. Luangmonkong, T., Suriguga, S., Mutsaers, H. A. M., Groothuis, G. M. M., Olinga, P., & Boersema, M. (2018). Targeting Oxidative Stress for the Treatment of Liver Fibrosis. In B. Nilius, P. DeTombe, T. Gudermann, R. Jahn, & R. Lill (Eds.), Reviews of Physiology, Biochemistry and Pharmacology (pp. 71-102). (Reviews of Physiology Biochemistry and Pharmacology; Vol. 175). Cham: Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/112_2018_10
  5. 2017
  6. Prins, G., Luangmonkong, T., Weymaere, J., Suriguga, S., Oosterhuis, D., Schuppan, D., ... Olinga, P. (2017). Studying Non-Alcoholic Fatty Liver Disease: Development of an Ex Vivo Model. 19-20. Abstract from 1st International Conference on Fatty Liver, Seville, Spain. https://doi.org/10.1159/000478719
  7. Stribos, E. G. D., Nielsen, S. H., Brix, S., Karsdal, M. A., Seelen, M. A., van Goor, H., ... Genovese, F. (2017). Non-invasive quantification of collagen turnover in renal transplant recipients. PLoS ONE, 12(4), [e0175898]. https://doi.org/10.1371/journal.pone.0175898
  8. 2016
  9. van den Brand, J. A. J. G., Mutsaers, H. A. M., van Zuilen, A. D., Blankestijn, P. J., van den Broek, P. H., Russel, F. G. M., ... Wetzels, J. F. M. (2016). Uremic Solutes in Chronic Kidney Disease and Their Role in Progression. PLoS ONE, 11(12), [0168117]. https://doi.org/10.1371/journal.pone.0168117
  10. 2015
  11. 2014
  12. Masereeuw, R., Mutsaers, H. A. M., Toyohara, T., Abe, T., Jhawar, S., Sweet, D. H., & Lowenstein, J. (2014). The kidney and uremic toxin removal: Glomerulus or tubule? SEMINARS IN NEPHROLOGY, 34(2), 191-208. https://doi.org/10.1016/j.semnephrol.2014.02.010
  13. 2013
  14. Mutsaers, H. A. M., Engelke, U. F. H., Wilmer, M. J. G., Wetzels, J. F. M., Wevers, R. A., van den Heuvel, L. P., ... Masereeuw, R. (2013). Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients. PLoS ONE, 8(8), [e71199]. https://doi.org/10.1371/journal.pone.0071199
  15. 2012
  16. 2011
  17. Mutsaers, H. A. M., van den Heuvel, L. P., Ringens, L. H. J., Dankers, A. C. A., Russel, F. G. M., Wetzels, J. F. M., ... Masereeuw, R. (2011). Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations. PLoS ONE, 6(4), [e18438]. https://doi.org/10.1371/journal.pone.0018438
  18. 2009

ID: 482024